TCTR20211109005招募中不适用
Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseases
Siriraj Hospital Mahidol University0 个研究点目标入组 400 人开始时间: 2021年11月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.The patient 18 years and older and diagnosis leukemia and lymphoma under treatment or is undergoing follow-up
- •2.the patient receive the first dose of COVID-19 vaccinate not limited to the brand name and has not been infected with covid-19 before.
排除标准
- •1 .Pregnant woman.
- •2. History of venous thromboembolism in the past 3 months.
- •3. History of receiving other vaccines within 28 days before vaccination against COVID-19.
研究者
相似试验
已完成
3 期
Hemostatic Changes Following COVID-19 VaccinatioTCTR20240812005Faculty of Medicine Siriraj Hospital195
招募中
不适用
COVID-19 Vaccine Efficacy in patients with Blood CancerACTRN12621000538842Royal Brisbane and Women's Hospital50
尚未招募
不适用
Adverse events following COVID-19 vaccinatioCTRI/2021/04/032823Dr Chandralekha
已完成
4 期
SARS-CoV2 vaccination and activation of the coagulation systemcovid-19thrombosis1004743810014523NL-OMON51038Academisch Medisch Centrum40
进行中（未招募）
1 期
SARS-CoV2 vaccination and activation of the clotting systemCoronavirus disease 2019 and thromboembolismEUCTR2021-001655-13-NLRadboudumc40